Javascript must be enabled to continue!
Can We Exclude the Diagnosis of Non-ST Segment Myocardial Infarction on the Basis of a Single Troponin I and a Symptom Duration ≥8 Hours?
View through CrossRef
Background. The use of a single troponin measurement to exclude the diagnosis of non-ST segment myocardial infarction (NSTEMI) in patients that present with ischemic symptom duration ≥8 hours is sometimes used in the Emergency Department. Study Objective. To describe the characteristics of patients with initial nondiagnostic troponin values who develop a positive troponin while in the Emergency Department and to evaluate whether NSTEMI can be excluded using symptom duration ≥8 hours and initial troponin I. Methods. Retrospective chart review of patients evaluated for NSTEMI in the Emergency Department. Results. 4,510 patients had at least two troponin I values obtained during the two-year study period. 115 (2.5%) of these patients had an initially nondiagnostic (<0.6 ng/mL) and subsequent positive (≥0.6 ng/mL) troponin I result. Twenty-five (22%) of the 115 had duration of symptoms ≥8 hours. Of these 25 patients, 18 had an intermediate first troponin value (i.e., >0.06 ng/mL, but <0.6 ng/mL). Only two of the remaining seven patients had a final primary diagnosis of NSTEMI. Conclusion. The use of a negative initial troponin I together with a symptom onset of ≥8 hours defines a population with a very low incidence of a hospital diagnosis of NSTEMI.
Title: Can We Exclude the Diagnosis of Non-ST Segment Myocardial Infarction on the Basis of a Single Troponin I and a Symptom Duration ≥8 Hours?
Description:
Background.
The use of a single troponin measurement to exclude the diagnosis of non-ST segment myocardial infarction (NSTEMI) in patients that present with ischemic symptom duration ≥8 hours is sometimes used in the Emergency Department.
Study Objective.
To describe the characteristics of patients with initial nondiagnostic troponin values who develop a positive troponin while in the Emergency Department and to evaluate whether NSTEMI can be excluded using symptom duration ≥8 hours and initial troponin I.
Methods.
Retrospective chart review of patients evaluated for NSTEMI in the Emergency Department.
Results.
4,510 patients had at least two troponin I values obtained during the two-year study period.
115 (2.
5%) of these patients had an initially nondiagnostic (<0.
6 ng/mL) and subsequent positive (≥0.
6 ng/mL) troponin I result.
Twenty-five (22%) of the 115 had duration of symptoms ≥8 hours.
Of these 25 patients, 18 had an intermediate first troponin value (i.
e.
, >0.
06 ng/mL, but <0.
6 ng/mL).
Only two of the remaining seven patients had a final primary diagnosis of NSTEMI.
Conclusion.
The use of a negative initial troponin I together with a symptom onset of ≥8 hours defines a population with a very low incidence of a hospital diagnosis of NSTEMI.
Related Results
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
Objectives
To investigate the clinical value of myocardial enzymes and troponin I combined detection for early diagnosis of acute myocardial infarction.
...
Additional PKA phosphorylation sites in human cardiac troponin I
Additional PKA phosphorylation sites in human cardiac troponin I
We used mass spectrometry to monitor cAMP‐dependent protein kinase catalysed phosphorylation of human cardiac troponin I in vitro. Phosphorylation of isolated troponin I by cAMP‐de...
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
ABSTRACT
The cardiac troponin complex, composed of troponins I, T, and C, plays a central role in regulating the calcium-dependent interactions between myosin and t...
Evaluation of First-Draw Whole Blood, Point-of-Care Cardiac Markers in the Context of the Universal Definition of Myocardial Infarction: A Comparison of a Multimarker Panel to Troponin Alone and to Testing in the Central Laboratory
Evaluation of First-Draw Whole Blood, Point-of-Care Cardiac Markers in the Context of the Universal Definition of Myocardial Infarction: A Comparison of a Multimarker Panel to Troponin Alone and to Testing in the Central Laboratory
Abstract
Context
.—Previous studies evaluating point-of-care testing (POCT) for cardiac biomarkers did not use current re...
Phosphorylation of troponin and the effects of interactions between the components of the complex
Phosphorylation of troponin and the effects of interactions between the components of the complex
1. The troponin complex from skeletal muscle contains approximately 1 mol of phosphate/80000g of complex, covalently bound to the troponin T component. 2. On prolonged incubation o...
Study of Ischemia Modified Albumin as New Potential Diagnostic Biomarker In Acute Myocardial Infarction.
Study of Ischemia Modified Albumin as New Potential Diagnostic Biomarker In Acute Myocardial Infarction.
Background: Because of the varied presentation and associated high mortality the identification of patients with acute myocardial infarction is very critical for the patient manage...
DIFFERENTIATING TROPONIN I AND CK-MB IN MYOCARDIAL INFARCTION DIAGNOSIS: A NOVEL APPROACH TO BIOMARKER COMPARISON
DIFFERENTIATING TROPONIN I AND CK-MB IN MYOCARDIAL INFARCTION DIAGNOSIS: A NOVEL APPROACH TO BIOMARKER COMPARISON
Background: Myocardial infarction (MI) is a life-threatening condition characterized by reduced blood supply to cardiac tissue, often leading to irreversible myocardial damage. Ear...
Misleading Elevation of Troponin T caused by Polymyositis
Misleading Elevation of Troponin T caused by Polymyositis
Background: Elevations of cardiac enzymes are commonly used to indicate myocardial ischemia, but they can be elevated due to other conditions. Different forms of Troponin (cTnT, sT...

